--- title: "Mereo BioPharma Received Notice of Noncompliance" type: "News" locale: "en" url: "https://longbridge.com/en/news/296351409.md" description: "Mereo BioPharma received a second notice from Nasdaq for noncompliance with the $1.00 minimum bid price requirement under Listing Rule 5550(a)(2). The company has been granted an additional 180-day compliance period ending February 16, 2027. To regain compliance, ADSs must maintain a closing bid of at least $1.00 for 10 consecutive business days. The notice does not immediately affect its Nasdaq listing." datetime: "2026-08-19T11:53:01.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296351409.md) - [en](https://longbridge.com/en/news/296351409.md) - [zh-HK](https://longbridge.com/zh-HK/news/296351409.md) generator: "portal-rs" --- # Mereo BioPharma Received Notice of Noncompliance On August 18, 2026, the company received a second notice from Nasdaq indicating it has not yet regained compliance with the $1.00 minimum bid price under Listing Rule 5550(a)(2) but is eligible for an additional 180-day compliance period until February 16, 2027. Compliance will be achieved if the ADSs maintain a closing bid of at least $1.00 for 10 consecutive business days. The notice has no immediate effect on the Nasdaq listing. Original SEC Filing: Mereo BioPharma Group plc \[ MREO \] - 8-K - Aug. 19, 2026 **Disclaimer** This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC. ### Related Stocks - [MREO.US](https://longbridge.com/en/quote/MREO.US.md) ## Related News & Research - [Wall Street banks set for banner year as Anthropic, SpaceX IPOs generate US$1 billion in fees](https://longbridge.com/en/news/306386521.md) - [Wall St Week Ahead-'Black Friday' brings consumer spending into focus for AI-rocked market](https://longbridge.com/en/news/306395310.md) - [Should Stronger Oncology Earnings Require Action From McKesson (MCK) Investors?](https://longbridge.com/en/news/306384915.md) - [Revolution Medicines (RVMD) Reports Fresh RASONQUE Data, Is The Stock Priced For Perfection?](https://longbridge.com/en/news/306378335.md) - [e.l.f. Beauty (ELF) Could Be 21% Undervalued As Sports And Retail Reach Expand](https://longbridge.com/en/news/306384935.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**